- Home
- Companies
- usa rhode island
- monoclonal secondary antibody
Refine by
Monoclonal Secondary Antibody Suppliers Serving Usa Rhode Island
91 companies found
based inAbingdon, UNITED KINGDOM
AMSBIO is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, ...
Clone OTI4C5, Anti-DDK (FLAG) monoclonal antibody, ...
based inRochester Hills, MICHIGAN (USA)
Oxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins and antibodies for biomedical research and drug discovery. The company’s primary focus is on the identification and assay of biomarkers for ...
based inPaoli, NEW JERSEY (USA)
Beta Lifescience is a professional biotech company committed to providing premium quality life science research reagents worldwide across research and diagnostic markets. Our strong portfolio of recombinant proteins, viral antigens, antibodies, ...
Beta Lifesciences has accumulated an extensive experience in the development of recombinant proteins. We have rich experience in the expression of recombinant proteins (antibodies, enzymes, membrane proteins, cytokines, etc.) in any species. We ...
based inSurrey, UNITED KINGDOM
Bioventix plc was founded in 2003 as a biotechnology business specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. Our antibody technology, laboratory and some of our team of ...
Bioventix has created a novel sheep hybridoma technology to produce stable and productive cell lines that secrete sheep monoclonal antibodies (SMAs) of very high affinity. The ultra-high affinity of Bioventix’s antibodies facilitates the ...
based inLake Linden, MICHIGAN (USA)
NECi Superior Enzymes, previously 'The Nitrate Elimination Company, Inc.', is a woman-owned small business located in Michigan's Upper Peninsula. NECi's specialty is designing and producing recombinant proteins for inclusion in quantification test ...
based inBerlin, GERMANY
Adrenomed AG is a privately-financed, clinical-stage biopharmaceutical company with a clear mission: developing precision medicine to rescue vascular integrity and saving the lives of critically ill patients with limited treatment options. The ...
The Company’s lead product candidate is Adrecizumab (HAM8101; INN: enibarcimab), a clinical-stage, first-in-class drug targeting loss of vascular integrity. The strong rationale for Adrecizumab is supported by the elegance of its mode of ...
based inShirley, MASSACHUSETTS (USA)
In 2022, we became part of Absolute Biotech, a new company that unites multiple life science brands into one organization specializing in antibody reagents and services. Learn more at absolutebiotech.com. The extensive LSBio reagent catalog contains ...
based inCambridge, MASSACHUSETTS (USA)
We are a group of individuals who know that there is a better way to develop drugs. Our business model and broad, science-based portfolio has attracted some of the brightest minds in drug development. Our team brings together more than 300 years of ...
BOS-371 is a highly potent monoclonal antibody targeting the Interleukin-1 Receptor Accessory Protein (IL1RAP), a prevalent tumor associated antigen driving tumor growth and immunosuppression. BOS-371 has also been Fc-engineered to enhance effector ...
based inGent, BELGIUM
RheaVita markets an innovative continuous freeze-drying technology for (bio)pharmaceutical products. Our manufacturing approach saves companies time and money, guarantees product quality and offers the supply chain greater flexibility, compared to ...
based inSantiago de Compostela, SPAIN
We are a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer. Our patented MPN Technology enables the discovery and development of new compounds involving intracellular ...
Our patented MPN Technology® enables the discovery and development of new compounds involving intracellular biologics, especially monoclonal antibodies (mAbs), to successfully engage previously undruggable targets. ...
based inLimerick, PENNSYLVANIA (USA)
Rockland Immunochemicals, Inc. offers a robust catalog of antibodies to suit any project. No matter the context—basic research to disease therapy, phosphorylated to methylated, and beyond—Rockland embraces the challenge to design, produce, validate, ...
CD45 is encoded by the PTPRC (Protein tyrosine phosphatase receptor type C) gene. CD45, also known as the leukocyte common antigen (LCA), is a member of the protein tyrosine phosphatase (PTP) family. It is present on all human leukocytes including ...
based inMalvern, PENNSYLVANIA (USA)
Shifa Biomedical Corporation (Shifa) is a drug discovery company in Malvern Pennsylvania. It is a privately held biopharmaceutical company dedicated to the cost-effective development of drugs for the treatment of cardiovascular disease. ...
LDLR is a cell-surface receptor that binds LDL-C and carries it into cells to the endosome for degradation and thus reduces the plasma level of LDL-C (Figure 1). However, PCSK9 controls the degradation of the LDLR in the liver (Figure 1) and ...
based inBoston, MASSACHUSETTS (USA)
AVEO is an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients. AVEO™s strategy is to focus its resources toward development and commercialization of its product candidates in ...
based inShanghai, CHINA
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 5 ...
(serplulimab injection, anti-PD-1 mAb), company’s first self-developed innovative monoclonal antibody, was approved by the NMPA for the treatment of Microsatellite Instability-High (MSI-H) solid tumors in March 2022, providing an alternative ...
based inXiangshan County, CHINA
NEWGEN BIOTECH (NINGBO) CO.,LTD is located in No. 5, Rongtai Road, Chengdong Industrial Park, Xiangshan County. It was established in December 2013. The high-tech bioengineering company of bio-enzyme preparation derivatives has developed into a ...
based inFarmingdale, NEW YORK (USA)
As an epigenetics company, Epigentek Group Inc. is the leading developer and provider of innovative technologies and products for epigenetic-related research. Founded in 2005, the company has since developed a comprehensive portfolio of proprietary ...
5-hydroxymethylcytosine (5-hmC), as a sixth DNA base with functions in transcription regulation, has been detected to be abundant in human and mouse brain and embryonic stem (ES) cells. In mammals, it can be generated by oxidation of ...
based inSpringdale, ARKANSAS (USA)
ImmunoVision is proud to be a member of the Erba Diagnostics family, a part of the global ERBA Mannheim Group. Earlier known by the name of IVAX Diagnostics, the company specializes in manufacture and marketing of proprietary diagnostic reagents, ...
Chromatically purified mouse monoclonal antibody to the Y-F-V-P-P-K-E-D-F-K epitope of the Scl-70 antigen, Clone 17F2, Isotype IgG, K. For use in standard solid phase ...
based inDallas, TEXAS (USA)
Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past thirty years, Santa Cruz Biotechnology has focused on the ongoing development of research monoclonal antibodies, ...
- Anti-p53 Antibody (DO-1) is a mouse monoclonal IgG2a κ p53 antibody, cited in 6,154 publications, provided at 200 µg/ml - N-terminal epitope mapping between amino acid residues 11-25 of p53 of human origin - Anti-p53 Antibody (DO-1) is recommended ...
based inSeattle, WASHINGTON (USA)
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative ADAPTIR™ and ADAPTIR-FLEX platform technologies to create therapeutic candidates designed to improve outcomes for ...
APVO603 is a dual agonist bispecific antibody employing a novel mechanism of action to simultaneously target 4-1BB (CD137) and OX40 (CD134), both members of the TNF-receptor family. Dual targeting of 4-1BB and OX40 provides synergistic ...
based inLouvain-la-Neuve, BELGIUM
MORE THAN 30 YEARS OF EXPERIENCE IN IVD (KITS & INSTRUMENTATION). DIAsource ImmunoAssays® S.A. (A BioVendor Group company) is an international diagnostic company based in Belgium with more than 30 years of experience in IVD (kits and ...
Clone: OBV4, Batch": [Batch dependent], Size: [> 1 mg], Format: Purified Unconjugated, Liquid, Concentration: [> 1 mg/mL, Batch dependent], Buffer: 0.05 M phosphate buffer, 0.1 M NaCI pH 7.2, Preservative: None, Purification: Protein G ...